| Literature DB >> 32722265 |
Alice Avancini1, Valeria Pala2, Ilaria Trestini3, Daniela Tregnago3, Luigi Mariani4, Sabina Sieri2, Vittorio Krogh2, Marco Boresta5, Michele Milella3, Sara Pilotto3, Massimo Lanza6.
Abstract
BACKGROUND: Despite the benefits related to physical exercise, large numbers of cancer patients are not sufficiently active.Entities:
Keywords: adherence; cancer; exercise; health promotion; preferences
Mesh:
Year: 2020 PMID: 32722265 PMCID: PMC7432474 DOI: 10.3390/ijerph17155351
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow of participants through the study.
General and tumor characteristics of 392 cancer patients† according to willingness to participate in a specifically designed exercise program.
| All | Willingness to Participate ‡ | |||||||
|---|---|---|---|---|---|---|---|---|
| Yes | Maybe | No | ||||||
| (392) | (179) | (134) | (79) | |||||
| No. | % | No. | % | No. | % | No. | ||
| <65 | 239 | 48 | 115 | 38 | 91 | 14 | 33 | 0.023 |
| ≥65 | 149 | 42 | 63 | 28 | 41 | 30 | 45 | |
|
| ||||||||
| Female | 238 | 51 | 121 | 32 | 77 | 17 | 40 | 0.023 |
| Male | 154 | 38 | 58 | 37 | 57 | 25 | 39 | |
|
| ||||||||
| Verona | 244 | 43 | 105 | 34 | 82 | 23 | 57 | 0.114 |
| Other | 148 | 50 | 74 | 35 | 52 | 15 | 22 | |
|
| ||||||||
| Elementary (up to 10–11 years) | 32 | 28 | 9 | 28 | 9 | 44 | 14 | 0.002 |
| Secondary (up to 14 years) | 119 | 41 | 49 | 37 | 44 | 22 | 26 | 0.451 |
| Secondary (up to 18–19 years) | 162 | 50 | 80 | 36 | 59 | 14 | 22 | 0.031 |
| College/University | 52 | 54 | 28 | 25 | 13 | 21 | 11 | 0.308 |
| Postgraduate | 18 | 50 | 9 | 33 | 6 | 17 | 3 | 0.920 |
|
| ||||||||
| Underweight | 19 | 58 | 11 | 32 | 6 | 11 | 2 | 0.455 |
| Normal weight | 228 | 46 | 104 | 34 | 78 | 20 | 46 | 0.994 |
| Overweight | 107 | 41 | 44 | 36 | 39 | 22 | 24 | 0.503 |
| Obese | 30 | 57 | 17 | 27 | 8 | 17 | 5 | 0.461 |
|
| ||||||||
| Single | 51 | 43 | 22 | 35 | 18 | 22 | 11 | 0.903 |
| Married | 269 | 45 | 122 | 35 | 94 | 20 | 53 | 0.819 |
| Divorced | 35 | 46 | 16 | 34 | 12 | 20 | 7 | 0.999 |
| Widowed | 34 | 56 | 19 | 24 | 8 | 21 | 7 | 0.371 |
|
| ||||||||
| Retired | 161 | 46 | 74 | 30 | 48 | 24 | 39 | 0.151 |
| Homemaker | 43 | 44 | 19 | 30 | 13 | 26 | 11 | 0.622 |
| Part-time employed | 45 | 49 | 22 | 42 | 19 | 9 | 4 | 0.118 |
| Full-time employed | 123 | 46 | 57 | 38 | 47 | 15 | 19 | 0.242 |
| Other | 20 | 35 | 7 | 35 | 7 | 30 | 6 | 0.462 |
|
| ||||||||
| Inadequate | 28 | 50 | 14 | 36 | 10 | 14 | 4 | 0.746 |
| Barely adequate | 120 | 45 | 54 | 40 | 48 | 15 | 18 | 0.152 |
| Adequate | 180 | 44 | 80 | 34 | 61 | 22 | 39 | 0.676 |
| More than adequate | 61 | 51 | 31 | 23 | 14 | 26 | 16 | 0.103 |
|
| ||||||||
| Insufficiently active | 363 | 45 | 162 | 35 | 127 | 20 | 75 | 0.338 |
| Active | 27 | 59 | 16 | 26 | 7 | 15 | 4 | |
|
| ||||||||
| Breast | 101 | 54 | 55 | 31 | 31 | 15 | 15 | 0.096 |
| Lung | 22 | 41 | 9 | 36 | 8 | 23 | 5 | 0.894 |
| Colorectum | 39 | 31 | 12 | 49 | 19 | 21 | 8 | 0.091 |
| Head/neck | 9 | 44 | 4 | 22 | 2 | 33 | 3 | 0.554 |
| Upper gastro-intestine | 166 | 46 | 77 | 35 | 58 | 19 | 31 | 0.821 |
| Gynecological | 8 | 50 | 4 | 38 | 3 | 13 | 1 | 0.862 |
| Urogenital | 19 | 53 | 10 | 21 | 4 | 26 | 5 | 0.450 |
| Melanoma | 14 | 21 | 3 | 29 | 4 | 50 | 7 | 0.015 |
| Other | 14 | 36 | 5 | 36 | 5 | 29 | 4 | 0.659 |
|
| ||||||||
| Unknown | 53 | 40 | 21 | 32 | 17 | 28 | 15 | 0.274 |
| In remission/cured | 62 | 56 | 35 | 27 | 17 | 16 | 10 | 0.178 |
| Early | 86 | 48 | 41 | 37 | 32 | 15 | 13 | 0.411 |
| Advanced | 85 | 38 | 32 | 40 | 34 | 22 | 19 | 0.239 |
| Metastatic | 106 | 47 | 50 | 32 | 34 | 21 | 22 | 0.866 |
|
| ||||||||
| Surgery | 215 | 44 | 95 | 32 | 69 | 24 | 51 | 0.167 |
| Chemotherapy | 329 | 44 | 144 | 36 | 119 | 20 | 66 | 0.102 |
| Radiation therapy | 113 | 44 | 50 | 29 | 33 | 27 | 30 | 0.119 |
| Hormone therapy | 50 | 56 | 28 | 30 | 15 | 14 | 7 | 0.249 |
| Other | 27 | 59 | 16 | 19 | 5 | 22 | 6 | 0.190 |
|
| ||||||||
| About to start | 11 | 55 | 6 | 27 | 3 | 18 | 2 | 0.829 |
| Ongoing | 325 | 44 | 144 | 35 | 115 | 20 | 66 | 0.452 |
| Completed | 35 | 51 | 18 | 29 | 10 | 20 | 7 | 0.728 |
| Unknown | 21 | 52 | 11 | 29 | 6 | 19 | 4 | 0.804 |
|
| ||||||||
| ≤30 months | 178 | 48 | 86 | 37 | 65 | 15 | 27 | 0.080 |
| ≥30 months | 214 | 43 | 93 | 32 | 69 | 24 | 52 | |
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019. ‡ Willingness to participate in exercise program assessed by the question: Would you be interested in participating in an exercise program designed for cancer patients? § Pearson’s chi-squared used the null hypotheses of no association between physical exercise level and other patient/disease characteristics. ¶ Body Mass Index categories are those of the World Health Organization [34]. †† Perceived income adequacy assessed by the question: Does your monthly income cover your monthly expenditure? ‡‡ Exercise level according to Leisure Score Index (LSI). Patients are active if LSI ≥24 and insufficiently active if LSI <24 [36]. §§ Treatments, which may be completed or in course, and are not mutually exclusive.
Characteristics of preceding week’s exercise in cancer patients† by age and sex.
| Exercise Frequency (Times/Week) by Intensity ‡ | All Patients | Age < 65 Years | Age ≥ 65 Years | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (392) | Men (81) | Women (158) | Men (71) | Women (78) | ||||||
| Mean (SD) § | Median (IQR) ¶ | Mean (SD) § | Median (IQR) ¶ | Mean (SD) § | Median (IQR) ¶ | Mean (SD) § | Median (IQR) ¶ | Mean (SD) § | Median (IQR) ¶ | |
| Strenuous | 0.20 | 0 | 0.21 | 0 | 0.29 | 0 | 0.13 | 0 | 0.08 | 0 |
| (0.84) | (0) | (0.85) | (0) | (1.03) | (0) | (0.70) | (0) | (0.42) | (0) | |
| Moderate | 0.71 | 0 | 0.64 | 0 | 0.77 | 0 | 0.61 | 0 | 0.75 | 0 |
| (1.43) | (1) | (1.30) | (1) | (1.40) | (1) | (1.53) | (0) | (1.53) | (1) | |
| Mild | 1.56 | 0 | 1.20 | 0 | 1.31 | 0 | 2.24 | 2 | 1.68 | 0 |
| (2.15) | (2) | (1.68) | (2) | (1.99) | (2) | (2.49) | (4) | (2.38) | (3) | |
|
| N | % | N | % | N | % | N | % | N | % |
| Insufficiently active | 363 | 93 | 76 | 94 | 144 | 92 | 66 | 94 | 74 | 95 |
| Sufficiently active | 27 | 7 | 5 | 6 | 13 | 8 | 4 | 6 | 4 | 5 |
|
| N | % | N | % | N | % | N | % | N | % |
| Often | 60 | 16 | 9 | 11 | 23 | 15 | 15 | 21 | 13 | 17 |
| Sometimes | 121 | 32 | 28 | 35 | 54 | 35 | 16 | 23 | 21 | 27 |
| Rarely/never | 204 | 53 | 43 | 54 | 77 | 50 | 39 | 56 | 43 | 56 |
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019. ‡ Exercise intensity according to [35]. § SD, standard deviation; ¶ IQR, interquartile range. †† Exercise level according to Leisure Score Index (LSI): active ≥24; insufficiently active <24 [36].
Exercise preferences in cancer patients †.
| Preference as Expressed by Answers to Questions | % | No. |
|---|---|---|
|
| ||
| Yes | 46 | 179 |
| No | 20 | 79 |
| Maybe | 34 | 134 |
|
| ||
| Oncologist | 57 | 224 |
| Nurse | 7 | 26 |
| Kinesiologist | 20 | 80 |
| Nutritionist | 20 | 80 |
| Physiotherapist | 30 | 118 |
| Another cancer patient | 3 | 11 |
| No preference | 20 | 79 |
| Other | 2 | 8 |
|
| ||
| Face to face | 72 | 270 |
| By telephone | 3 | 13 |
| Videotape | 2 | 9 |
| Television | 1 | 3 |
| Leaflet/pamphlet | 5 | 20 |
| Over the internet | 3 | 13 |
| No preference | 12 | 46 |
| Other | 1 | 2 |
|
| ||
| At home | 21 | 78 |
| At a community fitness center | 12 | 44 |
| At an adapted exercise fitness center | 22 | 83 |
| Outside | 27 | 103 |
| No preference | 18 | 70 |
| Other | 1 | 2 |
|
| ||
| Morning | 48 | 179 |
| Afternoon | 31 | 118 |
| Evening | 9 | 32 |
| No preference | 13 | 48 |
|
| ||
| Weekday | 70 | 256 |
| Weekend | 9 | 32 |
| No preference | 22 | 79 |
|
| ||
| Unsupervised | 15 | 56 |
| Supervised | 62 | 224 |
| No preference | 23 | 83 |
|
| ||
| Individual with a program to follow at home | 27 | 96 |
| Individual with personal trainer | 25 | 90 |
| In a group with a kinesiologist/physiotherapist/exercise specialist | 40 | 144 |
| Other | 8 | 30 |
|
| ||
| Same each time | 29 | 105 |
| Different each time | 34 | 123 |
| No preference | 37 | 135 |
|
| ||
| Nobody | 16 | 61 |
| Other cancer patients | 27 | 104 |
| Family members | 8 | 29 |
| Friends | 8 | 30 |
| A group | 13 | 47 |
| No preference | 27 | 101 |
| Other | 1.3 | 5 |
|
| ||
| Nobody | 13 | 48 |
| Exercise specialist | 22 | 83 |
| Neighbor | 1 | 5 |
| Colleague | 1 | 3 |
| Friend | 19 | 71 |
| Son/daughter | 13 | 47 |
| Spouse | 28 | 102 |
| Other relative | 3 | 10 |
|
| ||
| Never | 1 | 5 |
| Once a week | 15 | 54 |
| Twice a week | 37 | 136 |
| Three times a week | 30 | 111 |
| Four times a week | 5 | 19 |
| Five times a week | 5 | 19 |
| Six times a week | 1 | 5 |
| Seven times a week | 4 | 16 |
|
| ||
| Mild | 48 | 175 |
| Moderate | 39 | 141 |
| Strenuous | 7 | 24 |
| No preference | 6 | 23 |
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ‡ Replies add up to more than 694 as participants could choose more than one instructor.
Multivariable logistic modeling of associations of characteristics of cancer patients † with willingness ‡ to participate in an exercise program.
| All (No.) | Willing to Participate (No.) | Minimally-Adjusted Model § | Fully-Adjusted Model ¶ | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR †† | 95% CI†† | OR †† | 95% CI†† | ||||||
| Age | ≤65 y (reference) | 239 | 115 | 1 | 1 | ||||
| ≥65y | 149 | 63 | 0.84 | 0.55; 1.28 | 0.424 | 0.63 | 0.34; 1.15 | 0.085 | |
| Sex | Women (reference) | 238 | 121 | 1 | 1 | ||||
| Men | 154 | 58 | 0.61 | 0.40; 0.93 | 0.021 | 0.55 | 0.32; 0.94 | 0.029 | |
| Education | Up to age 14 years (reference) | 151 | 58 | 1 | 1 | ||||
| Beyond age 14 years | 241 | 121 | 1.60 | 1.04; 2.46 | 0.031 | 1.87 | 1.15; 3.04 | 0.011 | |
| Residence | Outside city (Reference) | 148 | 74 | 1 | 1 | ||||
| In Verona | 244 | 105 | 0.70 | 0.46; 1.07 | 0.100 | 0.61 | 0.38; 0.99 | 0.045 | |
| Perceived income adequacy | Inadequate (reference) | 148 | 68 | 1 | 1 | ||||
| Adequate | 244 | 111 | 1.06 | 0.69; 1.61 | 0.764 | 0.94 | 0.58; 1.51 | 0.785 | |
| Marital status | Married (reference) | 269 | 122 | 1 | 1 | ||||
| Single | 51 | 22 | 0.77 | 0.41; 1.44 | 0.366 | 0.64 | 0.31; 1.31 | 0.213 | |
| Divorced | 35 | 16 | 0.92 | 0.45; 1.89 | 0.94 | 0.43; 2.01 | |||
| Widowed | 34 | 19 | 1.88 | 0.85; 4.16 | 2.51 | 1.04; 6.04 | |||
| Occupational status | Retired (reference) | 161 | 74 | 1 | 1 | ||||
| Homemaker | 43 | 19 | 0.66 | 0.31; 1.33 | 0.354 | 0.73 | 0.33; 1.61 | 0.203 | |
| Part-time employed | 45 | 22 | 0.83 | 0.37; 1.62 | 0.67 | 0.30; 1.50 | |||
| Full-time employed | 123 | 57 | 0.83 | 0.46; 1.43 | 0.68 | 0.36; 1.29 | |||
| Other | 20 | 7 | 0.52 | 0.17; 1.33 | 0.58 | 0.18; 1.90 | |||
| Frequency of sweat-inducing activity | <1 time/week (reference) | 204 | 84 | 1 | 1 | ||||
| 1–2 times/week | 121 | 61 | 1.46 | 0.92; 2.32 | 0.037 | 1.50 | 0.91; 2.25 | 0.035 | |
| >2 times/week | 60 | 33 | 1.79 | 1.00; 3.23 | 1.92 | 1.92; 3.63 | |||
| Tumor site §§,¶¶ | Breast (reference) | 101 | 55 | 1 | 1 | ||||
| Lung | 22 | 9 | 0.60 | 0.24; 1.58 | 0.251 | 0.52 | 0.16; 1.68 | 0.423 | |
| Colorectal | 39 | 12 | 0.39 | 0.18; 0.86 | 0.46 | 0.18; 1.16 | |||
| Upper gastro-intestine | 166 | 77 | 0.73 | 0.44; 1.20 | 0.62 | 0.31; 1.24 | |||
| Urogenital system | 19 | 10 | 1.00 | 0.37; 2.75 | 1.02 | 0.28; 3.67 | |||
| Melanoma | 14 | 3 | 0.23 | 0.06; 0.88 | 0.13 | 0.03; 0.64 | |||
| Other sites6 | 31 | 13 | 0.66 | 0.29; 1.51 | 0.52 | 0.20; 1.40 | |||
| Disease status | Remission (reference) | 62 | 35 | 1 | 1 | ||||
| Early | 86 | 41 | 0.70 | 0.36; 1.36 | 0.145 | 0.61 | 0.27; 1.37 | 0.595 | |
| Advanced | 85 | 32 | 0.48 | 0.25; 0.95 | 0.65 | 0.29; 1.44 | |||
| Metastatic | 106 | 50 | 0.71 | 0.37; 1.44 | 0.72 | 0.30; 1.73 | |||
| Unknown | 53 | 21 | 0.51 | 0.24; 1.08 | 0.83 | 0.33; 2.06 | |||
| Chemotherapy | No (reference) | 55 | 31 | 1 | 1 | ||||
| Yes | 329 | 144 | 0.51 | 0.28; 0.92 | 0.026 | 0.45 | 0.23; 0.86 | 0.016 | |
| Surgery | No (reference) | 169 | 80 | 1 | 1 | ||||
| Yes | 215 | 95 | 0.91 | 0.60; 1.37 | 0.644 | 1.07 | 0.67; 1.71 | 0.787 | |
| Radiotherapy | No (reference) | 271 | 125 | ||||||
| Yes | 113 | 50 | 0.90 | 0.57; 1.41 | 0.650 | 0.97 | 0.58; 1.61 | 0.900 | |
| Hormone therapy | No (reference) | 334 | 147 | ||||||
| Yes | 50 | 28 | 1.45 | 0.78; 2.71 | 0.239 | 1.66 | 0.83; 3.32 | 0.152 | |
| Other treatments | No (reference) | 365 | 163 | ||||||
| Yes | 27 | 16 | 2.10 | 0.92; 4.82 | 0.077 | 1.89 | 0.81; 4.39 | 0.142 | |
| Treatment status | Completed (reference) | 36 | 18 | 1 | 1 | ||||
| About to start | 11 | 6 | 1.46 | 0.36; 5.84 | 0.695 | 1.80 | 0.31; 10.5 | 0.781 | |
| Ongoing | 325 | 144 | 0.79 | 0.37; 1.60 | 0.75 | 0.33; 1.71 | |||
| Unknown | 21 | 11 | 1.27 | 0.42; 3.83 | 1.72 | 0.45; 6.48 | |||
| Time from diagnosis | ≤30 months (reference) | 178 | 86 | 1 | 1 | ||||
| >30 months | 214 | 93 | 0.79 | 0.53; 1.19 | 0.265 | 0.68 | 0.42; 1.13 | 0.126 | |
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ‡ Willingness classified as yes vs. no/maybe. § Age- and sex-adjusted models, unless otherwise specified. ¶ Each variable adjusted for the following, unless otherwise specified: Sex (man vs. woman); Age (<65 y vs. ≥65 y); Education (more than 14 years of age vs. up to 14 years); Residence (outside city vs. win city of Verona); Perceived income adequacy (adequate vs. inadequate); Marital status (married, single, divorced, widowed); Occupational status (retired, homemaker, part-time employed, full-time employed, other); Frequency of sweat-inducing activity (<1 time/week, 1–2 times/week, >2 times/week); Tumor site (breast, lung, colorectum, upper gastro-intestine, urogenital system, melanoma, other); Disease status (in remission, early, advanced, metastatic, unknown); Chemotherapy (yes vs. no); Surgery (yes vs. no); Radiotherapy (yes vs. no); Hormone therapy (yes vs. no); Other treatments (yes vs. no); Treatment status (Completed, About to start, Ongoing, Unknown); Time from diagnosis (≤30 months, >30 months); “Lack of preference” variable (score 0 for no no-preference reply, score 1 for 1 no-preference reply, score 2 for 2 or more no-preference replies given to exercise preference questions); “Independence” variable (score 0 if “on my own” never chosen in exercise preference questions, score1 otherwise. †† OR (odds ratios), CI (confidence intervals), and p-values from multivariable logistic regression model. §§ Tumor sites with less than 10 patients are classified as “other site.” ¶¶ Models investigating tumor site (both minimally and fully adjusted models) were not adjusted for sex.
Multivariable regression modeling of associations of characteristics of 392 cancer patients † with exercise level ‡.
| No. | Exercise Level † | Minimally-Adjusted Model § | Fully-Adjusted Model ¶ | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | β †† | 95% CI †† | β †† | 95% CI †† | |||||
| Age | <65 y (reference) | 238 | 0.61 | 1.14 | Ref | Ref | ||||
| ≥65y | 148 | 0.42 | 0.91 | −0.17 | −0.39; 0.05 | 0.125 | 0.03 | −0.24; 0.31 | 0.801 | |
| Sex | Female (reference) | 237 | 0.58 | 1.10 | Ref | Ref | ||||
| Male | 153 | 0.46 | 0.99 | −0.10 | −0.32; 0.12 | 0.378 | −0.08 | −0.32; 0.16 | 0.489 | |
| Body Mass Index (kg/m2) | <25 (reference) | 245 | 0.67 | 1.21 | Ref | Ref | ||||
| ≥25 | 137 | 0.31 | 0.71 | −0.34 | −0.57; −0.11 | 0.003 | −0.33 | −0.57; −0.10 | 0.005 | |
| Education | Up to age 14 years (reference) | 149 | 0.32 | 0.75 | Ref | Ref | ||||
| Beyond age 14 years | 241 | 0.67 | 1.19 | 0.32 | 0.10; 0.55 | 0.004 | 0.32 | 0.09; 0.55 | 0.005 | |
| Perceived income adequacy | Inadequate (reference) | 147 | 0.52 | 1.14 | Ref | Ref | ||||
| Adequate | 243 | 0.55 | 1.01 | 0.06 | −0.16; 0.28 | 0.581 | 0.03 | −0.20; 0.25 | 0.826 | |
| Marital status | Married (reference) | 275 | 0.53 | 1.00 | Ref | Ref | ||||
| Single/other | 51 | 0.63 | 1.15 | 0.04 | −0.28; 0.37 | 0.86 | −0.05 | −0.39; 0.28 | 0.781 | |
| Divorced | 35 | 0.63 | 1.52 | 0.08 | −0.30; 0.46 | 0.01 | −0.37; 0.39 | |||
| Widowed | 34 | 0.41 | 0.90 | −0.06 | −0.46; 0.34 | −0.07 | −0.47; 0.34 | |||
| Occupation | Retired (reference) | 160 | 0.38 | 0.83 | Ref | Ref | ||||
| Homemaker | 43 | 0.40 | 0.87 | −0.05 | −0.42; 0.33 | 0.048 | 0.02 | −0.37; 0.41 | 0.073 | |
| Part-time employed | 45 | 0.66 | 1.14 | 0.19 | −0.14; 0.62 | 0.24 | −0.16; 0.64 | |||
| Full-time employed | 123 | 0.76 | 1.34 | 0.37 | 0.07; 0.66 | 0.32 | −0.01; 0.62 | |||
| Other | 19 | 0.38 | 0.74 | −0.01 | −0.53; 0.51 | 0.09 | −0.48; 0.66 | |||
| Tumor site ‡‡ | Breast (reference) | 101 | 0.63 | 1.27 | Ref | Ref | ||||
| Lung | 22 | 0.09 | 0.33 | −0.49 | −0.97; 0.02 | 0.579 | −0.52 | −1.05; 0.01 | 0.926 | |
| Colorectum | 39 | 0.32 | 0.94 | −0.30 | −0.67; 0.12 | −0.33 | −0.76; 0.10 | |||
| Upper gastro-intestine | 164 | 0.59 | 1.02 | −0.02 | −0.29; 0.24 | −0.03 | −0.36; 0.31 | |||
| Urogenital system | 19 | 0.39 | 0.94 | −0.18 | −0.70; 0.35 | −0.26 | −0.82; 0.31 | |||
| Melanoma | 14 | 0.79 | 1.10 | 0.17 | −0.43; 0.76 | 0.04 | −0.61; 0.68 | |||
| Other site §§ | 31 | 0.53 | 0.92 | −0.15 | −0.51; 0.34 | −0.18 | −0.65; 0.30 | |||
| Disease status | Remission (reference) | 62 | 0.85 | 1.25 | Ref | Ref | ||||
| Early | 85 | 0.73 | 1.31 | −0.10 | −0.44; 0.25 | 0.006 | 0.15 | −0.24; 0.54 | 0.010 | |
| Advanced | 84 | 0.30 | 0.82 | −0.51 | −0.86; −0.15 | −0.36 | −0.75; −0.02 | |||
| Metastatic | 106 | 0.50 | 0.97 | −0.30 | −0.63; 0.03 | −0.28 | −0.59; 0.08 | |||
| Unknown | 53 | 0.31 | 0.69 | −0.49 | −0.87; −0.10 | −0.43 | −0.81; 0.03 | |||
| Chemotherapy | No (reference) | 55 | 0.56 | 1.05 | Ref | Ref | ||||
| Yes | 327 | 0.54 | 1.07 | −0.06 | 0.36; 0.25 | 0.720 | 0.04 | −0.34; 0.38 | 0.914 | |
| Surgery | No (reference) | 167 | 0.48 | 0.98 | Ref | Ref | ||||
| Yes | 215 | 0.58 | 1.12 | 0.10 | −0.12; 0.31 | 0.366 | 0.07 | −0.16; 0.31 | 0.540 | |
| Radiotherapy | No (reference) | 269 | 0.55 | 1.10 | Ref | Ref | ||||
| Yes | 113 | 0.50 | 0.97 | −0.03 | −0.26; 0.21 | 0.833 | −0.10 | −0.36; 0.16 | 0.454 | |
| Hormone therapy | No (reference) | 332 | 0.53 | 1.07 | Ref | Ref | ||||
| Yes | 50 | 0.58 | 1.00 | −0.01 | −0.34; 0.32 | 0.955 | 0.10 | −0.26; 0.46 | 0.581 | |
| Other treatments | No (reference) | 363 | 0.53 | 1.05 | Ref | Ref | ||||
| Yes | 27 | 0.60 | 1.10 | 0.09 | −0.33; 0.51 | 0.682 | 0.10 | −0.37; 0.57 | 0.684 | |
| Treatment status | Completed (reference) | 35 | 0.83 | 1.31 | Ref | Ref | ||||
| About to start | 11 | 0.54 | 1.62 | −0.20 | −0.93; 0.53 | 0.184 | 0.18 | −0.67; 1.04 | 0.462 | |
| Ongoing | 323 | 0.50 | 1.00 | −0.30 | −0.67; 0.07 | −0.14 | −0.54; 0.26 | |||
| Unknown | 21 | 0.54 | 1.08 | −0.21 | −0.79; 0.37 | −0.08 | −0.72; 0.55 | |||
| Time from diagnosis | ≤30 months (reference) | 177 | 0.47 | 0.94 | Ref | Ref | ||||
| >30 months | 213 | 0.59 | 1.15 | 0.13 | −0.08; 0.34 | 0.225 | 0.15 | −0.08; 0.39 | 0.207 | |
† Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ‡ Exercise level assessed using Leisure Score Index [36]. § Age and sex adjusted models unless otherwise specified. ¶ Each variable was adjusted for the following, unless otherwise specified: Sex (man vs. woman); Age (<65y vs. ≥65y); Education (beyond 14 years of age vs. up to 14 years); Residence (outside city vs. in city of Verona); Perceived income adequacy (adequate vs. inadequate); Marital status (married, single, divorced, widow); Occupational status (retired, homemaker, part-time employed, full-time employed, other); Tumor site (breast, lung, colorectum, upper gastro-intestine, urogenital system, melanoma, other); Disease status (remission, early, advanced, metastatic, unknown); Chemotherapy (yes vs. no); Surgery (yes vs. no); Radiotherapy (yes vs. no); Hormone therapy (yes vs. no); Other treatments (yes vs. no); Treatment status (completed, about to start, ongoing, unknown); Time from diagnosis (≤30 months vs. 30 months). †† Beta coefficients 9 (β), confidence intervals (CI), and p values from multivariable regression models. The β coefficient is the amount of change in exercise level (Leisure Score Index) in each category of predictor variable compared to reference. ‡‡ Minimally and fully adjusted models for tumor site not adjusted for sex. §§ Tumor sites with <10 patients classified with another site.